Ferritin: Not Just an Iron Number — What It Reveals About Inflammation

Under normal, non-inflammatory conditions, serum ferritin roughly tracks total body iron stores. Low ferritin reliably means low iron. That's the straightforward part.

But the moment any degree of systemic inflammation enters the picture — and in modern humans living modern lives, some degree of low-grade inflammation is almost always present — ferritin becomes a hybrid signal. A ferritin of 220 ng/mL in a male patient, noted as within reference range (roughly 12–300 ng/mL for men), could reflect early iron accumulation, subclinical fatty liver, chronic low-grade inflammation, or the first whispers of metabolic syndrome. Each has completely different implications.

In precision medicine, the question isn't whether a value is “normal” but whether it's optimal. For men, that means roughly 40–150 ng/mL. For premenopausal women, 30–100 ng/mL. Values at the high end of the standard reference range — technically normal — frequently warrant investigation.

“You can be profoundly iron depleted long before you become anemic. Ferritin drops first, as the body pulls from storage to maintain hemoglobin. By the time the CBC looks abnormal, you've been symptomatic for months.”

And while elevated ferritin warrants attention, don't overlook the other end. Iron deficiency is staggeringly common — roughly 10–15% of premenopausal women in the U.S. are affected, and female endurance athletes are at even higher risk. You can be profoundly iron depleted long before you become anemic. Any ferritin below 30 ng/mL is suboptimal, regardless of hemoglobin.

Iron is a potent driver of oxidative stress through the Fenton reaction, generating free radicals that damage cell membranes, oxidize LDL cholesterol, and destabilize atherosclerotic plaques.

The Sullivan hypothesis, proposed in 1981, suggested that postmenopausal women lose their cardiovascular protection specifically because menstruation no longer depletes iron stores.[1] A 2025 review in Cardiovascular Research detailed a newly recognized mechanism called ferroptosis — iron-dependent lipid peroxidation driving cell death within plaques, promoting the kind of plaque rupture that causes heart attacks.[2]

A 2024 study in Blood Advances quantified a dose-response relationship: each additional decade spent with ferritin above 500 ng/mL was associated with 2.6-fold increased odds of diabetes, and above 1,000 ng/mL with 5.3-fold increased odds of heart disease.[3] The biology is instructive across a spectrum.

Elevated ferritin is independently associated with insulin resistance — even after controlling for inflammation.[4] Excess hepatic iron interferes with insulin signaling. Pancreatic beta cells are particularly vulnerable to iron-mediated oxidative stress, leading to gradual impairment of insulin synthesis. Elevated ferritin also tracks with higher triglycerides, lower HDL, hyperuricemia, and central obesity.

For the patient with a “normal” ferritin of 250, a fasting insulin that's slowly climbing, and a waist measurement that's inching up — ferritin is a metabolic warning sign that almost nobody is reading as one.

There's also the fatty liver connection. Non-alcoholic fatty liver disease affects roughly 30% of U.S. adults, and elevated ferritin with normal or mildly elevated transferrin saturation is one of the clinical patterns that should trigger evaluation. Fat-laden hepatocytes release ferritin as part of the inflammatory response, and catching fatty liver early — when it's still fully reversible — depends on connecting these dots.

Hereditary hemochromatosis — the most common genetic disorder in Northern Europeans, affecting roughly 1 in 200–250 Caucasians — causes iron to accumulate silently for decades before manifesting as liver disease, diabetes, cardiomyopathy, or joint destruction. The screening test is ferritin plus transferrin saturation. A ferritin that's persistently elevated with transferrin saturation above 45% should trigger HFE genetic testing.

Treatment is straightforward: therapeutic phlebotomy to reduce iron stores. Caught early, outcomes are excellent. Caught late, the damage is irreversible. In a precision medicine practice running whole genome sequencing, HFE carrier status can be identified before a patient develops a single symptom.

Ferritin should never be ordered in isolation. It comes alongside a complete iron panel (serum iron, TIBC, transferrin saturation) to distinguish genuine iron overload from inflammatory elevation, hs-CRP to gauge inflammatory contribution, liver enzymes, and fasting insulin because the ferritin-insulin resistance connection runs in both directions.

More importantly, track ferritin over time. A value creeping up from 80 to 180 over three years in someone who isn't supplementing iron tells you something about metabolic and inflammatory trajectory that a single snapshot never would. That trend gets completely lost when the lab stamps “within normal limits” and nobody revisits it.

Ferritin is cheap, universally available, and grossly underinterpreted. If your ferritin is sitting at the high end of the reference range and nobody has asked why, that's a missed opportunity. In precision medicine, missed opportunities are exactly what we're built to eliminate.